Modifies provisions relating to health care
SB178 is a health care bill that makes several changes to Missouri law affecting sexually transmitted infection treatment, prenatal testing, hospital transfer policies, and insurance coverage for contraception. It expands the state’s expedited partner therapy law so physicians and other authorized health care professionals may treat partners of patients with designated sexually transmitted infections, not just chlamydia or gonorrhea. The bill also broadens the infections covered to include chlamydia, gonorrhea, trichomoniasis, and any other STI designated by the Department of Health and Senior Services or recommended in CDC guidelines.
The bill adds a new requirement for prenatal blood testing and treatment protocols. It requires testing for syphilis, hepatitis B, hepatitis C, and HIV during pregnancy and after birth, with treatment and newborn hepatitis B prophylaxis to follow current medical guidance. It also creates a new insurance coverage mandate for self-administered hormonal contraceptives, requiring health plans that cover these drugs to reimburse providers or dispensing entities for up to a one-year supply beginning in 2026, subject to the same deductible and copay rules as similar services.
In addition, SB178 repeals an existing mammography notice statute and replaces it with a new exemption for specialty hospitals from certain sexual assault transfer requirements if they have a policy to transfer victims to an appropriate hospital with an emergency department. The bill also removes the prior dense-breast notification law from the statute books. Overall, the measure updates several public health and insurance provisions and shifts some implementation authority to the Department of Health and Senior Services and the Division of Professional Registration.
The general sentiment reflected by the bill text is pro-public-health and pro-access to care, with an emphasis on expanding treatment options, improving prenatal screening, and increasing contraceptive access. Because there are no committee transcripts or recorded votes provided, there is no documented public debate or formal vote history to indicate broader support or opposition.
Notable points of contention, based on the bill’s structure, would likely include the expanded authority for expedited partner therapy without an established patient relationship, the insurance mandate for a one-year contraceptive supply, and the repeal of the dense-breast notification provisions. The specialty hospital exemption from sexual assault transfer rules could also draw concern from patient advocates or hospital regulators, while providers may focus on liability protections and rulemaking authority.
SB178 would amend Missouri’s health care statutes by expanding expedited partner therapy under section 191.648, adding a new prenatal testing and treatment framework in section 210.030, creating a contraceptive coverage mandate in new section 376.1240, and repealing the prior mammography dense-breast notice law in section 192.769. It also adds a new exemption for specialty hospitals from certain transfer requirements related to sexual assault victims, provided they maintain a transfer policy. The bill affects physicians, other prescribing health care professionals, hospitals, prenatal care providers, health insurers, pharmacies or dispensing entities, and state health agencies responsible for rulemaking and implementation.
No committee transcript or vote record is provided, so there is no direct evidence of floor or committee sentiment. Based on the bill’s provisions, the measure appears generally supportive of expanded public health interventions, reproductive health access, and standardized prenatal screening. The absence of recorded opposition or amendment debate makes it impossible to identify a documented partisan or stakeholder split from the supplied materials.
The most likely areas of contention are the expansion of expedited partner therapy to additional sexually transmitted infections and the ability to prescribe to partners without an established physician-patient relationship, which may raise concerns about oversight and liability. The contraceptive coverage requirement for up to a one-year supply may also be contested by insurers over cost and benefit design. Repealing the dense-breast notification statute could concern breast cancer advocates, while the specialty hospital exemption from sexual assault transfer provisions may be questioned by patient safety and victim advocacy groups. The bill does provide civil immunity for providers using expedited partner therapy except in cases of negligence, recklessness, bad faith, or malicious purpose, which may be intended to address some provider concerns.